Richard Reinisch files SEC Form 4 disclosures for LA JOLLA PHARMACEUTICAL CO. They have made 1 open-market trade across 1 company since 2010, most recently 2013-03-19.
CIK 0001572691
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $120K since 2010, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LJPC | 20 | $124 |
Shares reported on the most recent Form 4, priced at the 2013-03-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LJPC | BUY | 2010-03-12 | 2013-03-22 | $0.11 | $120K | -40.0% | -4.4% | -4.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.